These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 24943989)
21. N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity. Kehlen A; Haegele M; Böhme L; Cynis H; Hoffmann T; Demuth HU Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28739588 [TBL] [Abstract][Full Text] [Related]
22. Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain. Hartlage-Rübsamen M; Staffa K; Waniek A; Wermann M; Hoffmann T; Cynis H; Schilling S; Demuth HU; Rossner S Int J Dev Neurosci; 2009 Dec; 27(8):825-35. PubMed ID: 19699792 [TBL] [Abstract][Full Text] [Related]
23. Identification of thyrotropin-releasing hormone as hippocampal glutaminyl cyclase substrate in neurons and reactive astrocytes. Waniek A; Hartlage-Rübsamen M; Höfling C; Kehlen A; Schilling S; Demuth HU; Roßner S Biochim Biophys Acta; 2015 Jan; 1852(1):146-55. PubMed ID: 25446989 [TBL] [Abstract][Full Text] [Related]
24. Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors. Xu C; Wang YN; Wu H J Med Chem; 2021 May; 64(10):6549-6565. PubMed ID: 34000808 [TBL] [Abstract][Full Text] [Related]
25. [A pathogenic mechanism of N-terminally pyroglutamylated Aβ and possible application of Alzheimer's disease by inhibition of the pyroglutamylation]. Iwata N; Asai M Rinsho Shinkeigaku; 2012; 52(11):1162-4. PubMed ID: 23196550 [TBL] [Abstract][Full Text] [Related]
26. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease. Hartlage-Rübsamen M; Waniek A; Meissner J; Morawski M; Schilling S; Jäger C; Kleinschmidt M; Cynis H; Kehlen A; Arendt T; Demuth HU; Rossner S Acta Neuropathol; 2015 Apr; 129(4):565-83. PubMed ID: 25666182 [TBL] [Abstract][Full Text] [Related]
27. Disturbed Ca2+ homeostasis increases glutaminyl cyclase expression; connecting two early pathogenic events in Alzheimer's disease in vitro. De Kimpe L; Bennis A; Zwart R; van Haastert ES; Hoozemans JJ; Scheper W PLoS One; 2012; 7(9):e44674. PubMed ID: 22970285 [TBL] [Abstract][Full Text] [Related]
28. Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients. Bridel C; Hoffmann T; Meyer A; Durieux S; Koel-Simmelink MA; Orth M; Scheltens P; Lues I; Teunissen CE Alzheimers Res Ther; 2017 Jun; 9(1):38. PubMed ID: 28587659 [TBL] [Abstract][Full Text] [Related]
29. An overview of glutaminyl cyclase inhibitors for Alzheimer's disease. Coimbra JR; Sobral PJ; Santos AE; Moreira PI; Salvador JA Future Med Chem; 2019 Dec; 11(24):3179-3194. PubMed ID: 31838899 [TBL] [Abstract][Full Text] [Related]